Martin Meyer Selected Research

Martin Meyer Research Topics

Disease

10	Tinnitus 12/2023 - 01/2017
3	Neoplasms (Cancer) 01/2020 - 07/2002
3	Hearing Loss (Hearing Impairment) 01/2017 - 10/2011
3	Ototoxicity 11/2014 - 10/2011
2	Infections 04/2023 - 11/2014
2	Amyloidosis 10/2021 - 11/2020
2	Sleepiness 04/2021 - 01/2021
2	Prostatic Neoplasms (Prostate Cancer) 04/2015 - 11/2012
1	Heart Arrest (Cardiac Arrest) 12/2023
1	Out-of-Hospital Cardiac Arrest 12/2023
1	Coma (Comas) 12/2023
1	Renal Insufficiency (Renal Failure) 10/2023
1	Rectal Neoplasms (Rectal Cancer) 08/2023
1	Thyroid Neoplasms (Thyroid Cancer) 12/2022
1	Transthyretin-Related Hereditary Amyloidosis 10/2021
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2021
1	Poisoning 01/2021
1	Cardiogenic Shock 01/2021
1	Atrophy 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Multiple Myeloma 11/2020
1	Immunoglobulin Light-chain Amyloidosis 11/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Dyslexia (Alexia) 07/2019
1	Insulin Resistance 12/2018
1	Myocardial Infarction 02/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2017
1	ST Elevation Myocardial Infarction 02/2017
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Amebic Liver Abscess 01/2016
1	Tuberculosis (Tuberculoses) 11/2014
1	Sepsis (Septicemia) 11/2014
1	Anaphylaxis (Anaphylactic Shock) 05/2014
1	Deafness (Deaf Mutism) 02/2012
1	Thrombosis (Thrombus) 07/2010
1	Neointima 07/2010
1	Thrombocytopenia (Thrombopenia) 04/2010
1	Type 2 Diabetes Mellitus (MODY) 01/2010
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2010
1	Glioblastoma (Glioblastoma Multiforme) 09/2009
1	Spinal Cord Injuries (Spinal Cord Injury) 03/2009
1	Stroke (Strokes) 03/2009
1	Neoplasm Metastasis (Metastasis) 07/2002
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2002

Drug/Important Bio-Agent (IBA)

3	AminoglycosidesIBA 11/2014 - 10/2011
2	Proteins (Proteins, Gene)FDA Link 04/2023 - 11/2020
2	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 12/2018
2	Prealbumin (Transthyretin)IBA 10/2021 - 11/2020
2	apramycinIBA 11/2014 - 07/2012
1	Complement System Proteins (Complement)IBA 12/2023
1	CV38-142IBA 04/2023
1	MelatoninIBA 04/2021
1	Caffeine (No Doz)FDA LinkGeneric 01/2021
1	Temazepam (Nocturne)FDA LinkGeneric 01/2021
1	AA amyloidosisIBA 11/2020
1	Amyloidogenic ProteinsIBA 11/2020
1	E 10 (E-10)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 02/2017
1	Virulence Factors (Pathogenicity Factors)IBA 01/2016
1	AerosolsIBA 11/2014
1	Amikacin (A.M.K)FDA LinkGeneric 11/2014
1	2-deoxystreptamineIBA 07/2012
1	tuberactinomycinIBA 10/2011
1	FibrinIBA 07/2010
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2010
1	HDL LipoproteinsIBA 01/2010
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2010
1	EnzymesIBA 09/2009
1	Topotecan (Hycamtin)FDA LinkGeneric 09/2009
1	Anticonvulsants (Antiepileptic Drugs)IBA 09/2009
1	Small Interfering RNA (siRNA)IBA 11/2006
1	DNA (Deoxyribonucleic Acid)IBA 11/2006
1	Dihydrotachysterol (AT 10)IBA 07/2002

Therapy/Procedure

11	Therapeutics 08/2023 - 11/2006
6	Neurofeedback 01/2023 - 01/2017
3	Radiotherapy 04/2015 - 07/2002
2	Resuscitation 10/2023 - 01/2021
2	Transcranial Direct Current Stimulation 05/2022 - 07/2019
1	Critical Care (Surgical Intensive Care) 12/2023
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2023
1	Treatment Delay 10/2021
1	Extracorporeal Membrane Oxygenation 01/2021
1	Hearing Aids (Hearing Aid) 01/2017
1	Aftercare (After-Treatment) 11/2012
1	Cochlear Implants (Cochlear Implant) 02/2012
1	Drug-Eluting Stents 07/2010
1	Stents 07/2010
1	Gluten-Free Diet 04/2010
1	Cystectomy 07/2002
1	Chemoradiotherapy 07/2002